Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts
Tài liệu tham khảo
Cals-Grierson, 2004, Nitric oxide function in the skin, Nitric Oxide, 10, 179, 10.1016/j.niox.2004.04.005
Clancy, 1998, The role of nitric oxide in inflammation and immunity, Arthritis Rheum., 41, 1141, 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S
Matucci, 2002, Beauty and the beast. The nitric oxide paradox in systemic sclerosis, Rheumatology (Oxford), 41, 843, 10.1093/rheumatology/41.8.843
Chu, 1999, Up-regulation by human recombinant transforming growth factor beta-1 of collagen production in cultured dermal fibroblasts is mediated by the inhibition of nitric oxide signaling, J. Am. Coll. Surg., 188, 271, 10.1016/S1072-7515(98)00303-2
Kim, 1999, Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide, J. Mol. Cell. Cardiol., 31, 457, 10.1006/jmcc.1998.0887
Kolpakov, 1995, Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells, Circ. Res., 76, 305, 10.1161/01.RES.76.2.305
Myers, 1998, Vascular endothelial cell regulation of extracellular matrix collagen: role of nitric oxide, Arterioscler. Thromb. Vasc. Biol., 18, 717, 10.1161/01.ATV.18.5.717
Cao, 1997, Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target, Biochem. J., 324, 305, 10.1042/bj3240305
Craven, 1997, Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells, Diabetes, 46, 671, 10.2337/diabetes.46.4.671
Trachtman, 1995, Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells, Biochem. Biophys. Res. Commun., 207, 120, 10.1006/bbrc.1995.1161
Owens, 1996, Inhibition of pleural mesothelial cell collagen synthesis by nitric oxide, Free Radic. Biol. Med., 21, 601, 10.1016/0891-5849(96)00159-1
Genovese, 2005, Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury, Respir. Res., 6, 58, 10.1186/1465-9921-6-58
Giri, 2002, Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice, Nitric Oxide, 7, 109, 10.1016/S1089-8603(02)00102-7
Ferrini, 2002, Antifibrotic role of inducible nitric oxide synthase, Nitric Oxide, 6, 283, 10.1006/niox.2001.0421
Thornton, 1998, Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds, Biochem. Biophys. Res. Commun., 246, 654, 10.1006/bbrc.1998.8681
Trachtman, 1996, Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells, Biochem. Biophys. Res. Commun., 218, 704, 10.1006/bbrc.1996.0125
Zaragoza, 2002, Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium, Kidney Int., 61, 804, 10.1046/j.1523-1755.2002.00224.x
Akool, 2005, Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway, J. Biol. Chem., 280, 39403, 10.1074/jbc.M504140200
Saura, 2005, Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells, Circ. Res., 97, 1115, 10.1161/01.RES.0000191538.76771.66
Valente, 2003, L-Arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures, Nitric Oxide, 9, 229, 10.1016/j.niox.2003.12.002
Beltran, 2000, Oxidative stress and S-nitrosylation of proteins in cells, Br. J. Pharmacol., 129, 953, 10.1038/sj.bjp.0703147
Beckman, 1996, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly, Am. J. Physiol, 271, C1424, 10.1152/ajpcell.1996.271.5.C1424
Black, 1998, Scleroderma and related disorders in adults and children, 1217
Leask, 2004, Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma, J. Invest. Dermatol., 122, 1, 10.1046/j.0022-202X.2003.22133.x
Cotton, 1999, Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin, J. Pathol., 189, 273, 10.1002/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.0.CO;2-4
Yamamoto, 1998, Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis, J. Rheumatol., 25, 314
Dooley, 2006, Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine, Rheumatology (Oxford), 45, 676, 10.1093/rheumatology/kei276
Sambo, 2001, Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway, Arthritis Rheum., 44, 2653, 10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1
Sambo, 1999, Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion, J. Invest. Dermatol., 112, 78, 10.1046/j.1523-1747.1999.00476.x
Bruckdorfer, 1995, Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis, Arthritis Rheum., 38, 1060, 10.1002/art.1780380807
Denton, 1999, Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon, Rheumatology (Oxford), 38, 309, 10.1093/rheumatology/38.4.309
Naseem, 1995, Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets, Biochem. J., 310, 149, 10.1042/bj3100149
1980, Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis Rheum., 23, 581, 10.1002/art.1780230510
Abraham, 1991, Expression and function of surface antigens on scleroderma fibroblasts, Arthritis Rheum., 34, 1164, 10.1002/art.1780340913
Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4
Leon, 1985, Effect of streptococcal lipoteichoic acid on prolyl hydroxylase activity as related to collagen formation in mouse fibroblast monolayers, Infect. Immun., 50, 745, 10.1128/IAI.50.3.745-752.1985
Peterkofsky, 1975, Modification of the tritium-release assays for prolyl and lysyl hydroxylases using Dowex-50 columns, Anal. Biochem., 66, 279, 10.1016/0003-2697(75)90747-2
Trupin, 1982, Assay of prolyl hydroxylase in cultured fibroblast monolayers, Anal. Biochem., 121, 219, 10.1016/0003-2697(82)90470-5
Keefer, 1996, “NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms, Methods Enzymol., 268, 281, 10.1016/S0076-6879(96)68030-6
Kivirikko, 1989, Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit, FASEB J., 3, 1609, 10.1096/fasebj.3.5.2537773
Pryor, 1995, The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide, Am. J. Physiol., 268, L699
Chakravortty, 1997, Induction of cell proliferation and collagen synthesis in human small intestinal lamina propria fibroblasts by lipopolysaccharide: possible involvement of nitric oxide, Biochem. Biophys. Res. Commun., 240, 458, 10.1006/bbrc.1997.7680
Witte, 2000, Enhancement of fibroblast collagen synthesis by nitric oxide, Nitric Oxide, 4, 572, 10.1006/niox.2000.0307
Curran, 1991, Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis, FASEB J., 5, 2085, 10.1096/fasebj.5.7.1707021
Garg, 1990, Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism, Biochem. Biophys. Res. Commun., 171, 474, 10.1016/0006-291X(90)91417-Q
Davidson, 1997, Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms, J. Biol. Chem., 272, 345, 10.1074/jbc.272.1.345
Halliwell, 1996, Vitamin C: antioxidant or pro-oxidant in vivo?, Free Radic. Res., 25, 439, 10.3109/10715769609149066
Heller, 1999, L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells, J. Biol. Chem., 274, 8254, 10.1074/jbc.274.12.8254
May, 2000, How does ascorbic acid prevent endothelial dysfunction?, Free Radic. Biol. Med., 28, 1421, 10.1016/S0891-5849(00)00269-0
Herrick, 1994, Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis, J. Rheumatol., 21, 1477
Murad, 1981, Regulation of collagen synthesis by ascorbic acid, Proc. Natl. Acad. Sci. USA, 78, 2879, 10.1073/pnas.78.5.2879
Kawaguchi, 1992, Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis, J. Rheumatol., 19, 1195
Kawaguchi, 1992, Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: an approach to the treatment of systemic sclerosis, J. Rheumatol., 19, 1710
Peltonen, 1985, Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts, J. Invest. Dermatol., 84, 14, 10.1111/1523-1747.ep12274596
Paik, 2001, The nitrite/collagen reaction: non-enzymatic nitration as a model system for age-related damage, Connect. Tissue Res., 42, 111, 10.3109/03008200109014253
Siwik, 2001, Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts, Am. J. Physiol. Cell Physiol., 280, C53, 10.1152/ajpcell.2001.280.1.C53
Szabo, 1996, DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite, Free Radic. Biol. Med., 21, 855, 10.1016/0891-5849(96)00170-0
Casciola-Rosen, 1997, Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis, J. Exp. Med., 185, 71, 10.1084/jem.185.1.71
Herrick, 2001, Antibodies against oxidized low-density lipoproteins in systemic sclerosis, Rheumatology (Oxford), 40, 401, 10.1093/rheumatology/40.4.401
Stein, 1996, Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma, Arthritis Rheum., 39, 1146, 10.1002/art.1780390711
